Compound class:
Synthetic organic
Comment: Firzacorvir is an antiviral agent. It acts as an inhibitor of hepatitis B virus (HBV) core protein (a.k.a. capsid assembly modulator or core protein allosteric modulator [1]), and via this mechanism it disrupts HBV replication. This chemical structure was obtained from INN proposed list 124 (December 2020).
|
|
References |
1. Mak LY, Wong DK, Seto WK, Lai CL, Yuen MF. (2017)
Hepatitis B core protein as a therapeutic target. Expert Opin Ther Targets, 21 (12): 1153-1159. [PMID:29065733] |